OIM Analysis 9 offers intuitive tools for EBSD analysis, enabling users to partition data and refine quality for deeper insights into microstructural behavior.
The biopharmaceutical industry is undergoing a structural shift. For decades, contract development and manufacturing organisations (CDMOs) have operated through fragmented models, with drug substance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results